President Joe Biden arrives at the White House after spending the weekend at his Delaware home, Monday, May 17, 2021, in Washington. (AP Photo/Evan Vucci)WASHINGTON (AP) — President Joe Biden will announce Monday that the U.S. will share an additional 20 million doses of COVID-19 vaccines with the world in the coming six weeks, the White House said.
The doses would come from existing U.S. production of Pfizer, Moderna or Johnson & Johnson vaccine stocks, according White House press secretary Jen Psaki, who said more details would be released in the coming days.
It comes on top of the Biden's administration’s prior commitment to share about 60 million doses of the AstraZeneca vaccine, which is not yet authorized for use in the U.S., by the end of June. The AstraZeneca doses will be available to ship once they clear a safety review by the Food and Drug Administration.
Biden is also tapping COVID-19 coordinator Jeff Zients to lead the administration's efforts to share doses with the world. The Biden administration has yet to announce how they will be shared or which countries will receive them.
To date, the U.S. has shared about 4.5 million doses of AstraZeneca vaccine with Canada and Mexico.
Before you consider Johnson & Johnson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.
While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
